# Wisp reviews (2026): GLP-1 telehealth sellers | This GLP

A daily sublingual drop at $225 a month, which the seller says has not yet been tested in the human body.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/wisp
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Daily drops, untested in people

# Wisp review

A daily sublingual drop at $225 a month, which the seller says has not yet been tested in the human body.

## The verdict

Wisp sells compounded semaglutide as a daily sublingual drop at $225 a month for a 28-day bottle. Its own FAQ says the formulation has not yet been tested within the human body. A $99 monthly check-in appears separately in the program FAQ.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide

Form

Oral

States

27

From

From $225/mo

Dose published

Yes

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

Availability

26 states and DC

Wisp is a telehealth company focused on sexual and reproductive health, with a weight care section. Its GLP-1 is a 15 mL bottle of compounded semaglutide drops, taken under the tongue once daily. The weight care shop page lists no injection and no tirzepatide. The drops are sold for delivery only.

1.  ## Who writes the prescription, and what do they see?
    
    A provider reviews a medical history submitted through the platform before prescribing. The seller says patients hear from a provider 24 to 72 hours after the consult request. Providers are described as board-certified. One physician, a DO, is named on the weight care team panel. The prescribing clinician for a given patient is not named in advance.
    
    The program FAQ describes a monthly cycle. After three weeks the card is authorized for the check-in, and the provider reviews progress before the refill. The check-in is then charged, together with the medication when delivery is chosen. The same process repeats each month.
    
2.  ## What happens when the dose goes up?
    
    The bottle is labeled 0.3 mg to 1.0 mg, a 28-day supply taken once daily. The lowest dose goes into the cart first, and the provider adjusts from there. The directions let the patient self-advance to the next dose if it is tolerated, per the prescription. A price for higher doses is not stated.
    
3.  ## What the price includes
    
    The drops are $225 a month, and six months at that rate is $1,350. The weight care FAQ adds a $99 check-in charged each month. The product page does not say whether $225 already includes it. That question is worth settling before the first refill.
    
4.  ## What it claims, and what it cites
    
    The drops are compounded by a 503A pharmacy that Wisp does not name. The FAQ states compounded [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) is not FDA-approved. No approved semaglutide product is a sublingual drop. The weight-loss trials of semaglutide tested a weekly injection and a daily tablet, so their results were not measured in this form. The seller's absorption data come from lab tests on human-derived tissue.
    

## Where it holds up, and where it does not

-   Strength: Seller discloses the drops are untested in people
-   Strength: No refrigeration needed for the drops
-   Strength: Dose range printed on the product page
-   Limitation: No human testing of this formulation
-   Limitation: Monthly check-in charge sits beside the price
-   Limitation: Served in 26 states and DC
-   Limitation: No tirzepatide or injection on the shop page

## What the evidence says about this kind of treatment

The assessment above is about Wisp. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader who will not inject and accepts a formulation without human data.

Wrong for

A reader who wants the form the semaglutide trials actually tested.

## The evidence behind what Wisp prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    

## How Wisp compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Revel Health | A reader who wants an oral and expects to pay less for it, which on this seller is what happens. |  |
| Zera Health | A reader who budgets from the monthly rate printed beside the first-month offer. |  |
| HealthSource | Readers who want the compounding source identified and the contents itemized |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Genesis Lifestyle Medicine](https://thisglp.com/reviews/genesis-lifestyle-medicine) [Gide Health](https://thisglp.com/reviews/gide-health) [Glow](https://thisglp.com/reviews/glow) [GOAL.MD](https://thisglp.com/reviews/goal-md) [GoodLife Health](https://thisglp.com/reviews/goodlife-health) [Happy Care Meds](https://thisglp.com/reviews/happy-care-meds)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Has this drop been tested in people?

Not according to Wisp. Its FAQ says lab tests on human-derived tissue suggest absorption, but the formulation has not yet been tested within the human body.

Is there a charge besides the $225?

The weight care FAQ describes a $99 monthly check-in. The product page does not say whether $225 already includes it.

Which states are served?

Twenty-six states and Washington, D.C., as listed in the product page FAQ.

Is Wisp legit?

Wisp is a GLP-1 telehealth sellers service. Its stated availability: 26 states and DC. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.

Is Wisp expensive compared with other GLP-1 telehealth sellers?

Wisp publishes a starting figure of $225/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Wisp above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
